Consistent with the above studies, we also detected elevated levels of anti-GNA11 autoantibody in sera of ESCC patients, which may indicate changes in GNA11 gene during the original initiation of ESCC. This evidence concerns the gene GNA11 and esophageal squamous cell carcinoma.